P/E Ratio
Updated 55h ago
Sector Performance
70th percentileFCX
32.8x
Sector Median
24.7x
Sector Avg
36.0x
Deep Analysis
The P/E ratio of 32.8x means investors are paying $32.80 for every $1 of FCX’s earnings, indicating the stock trades at a premium relative to its profits.
This is above the sector median of 24.8x, placing FCX in the 70th percentile among sector peers—meaning it is more expensive than 70% of comparable companies. The year-over-year change is not available, but the quarter-over-quarter change shows a decline of -7.8%, suggesting the premium is narrowing. A high P/E combined with a downward trend can signal that earnings growth is catching up to the price or that market sentiment is cooling, reducing the risk of a severe overvaluation. For investors, this mix implies a moderate risk: the stock remains costly relative to peers, but the recent compression may lower the downside if earnings hold. This metric supports the overall CAUTIOUS verdict, as the elevated valuation compared to the sector median highlights limited margin of safety, while the declining P/E offers a slight counterbalance without confirming a clear value opportunity.
Frequently Asked Questions
What does the P/E Ratio tell investors about FCX?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are FCX's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master FCX's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full FCX research report →FCX
32.8x
Sector Median
24.7x
Sector Avg
36.0x
How FCX's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.